Gibson Christopher's Form 4 filing
Recursion Pharmaceuticals, Inc. (RXRX) · filed Jun 7, 2024
- Accession no.
- 0001601830-24-000077
- Filed
- Jun 7, 2024
- Trade date
- Jun 5-6, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $871.0K. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0001601830-24-000102 (Jul 12, 2024). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gibson ChristopherCIK 0001856369 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2024 | Class A Common Stock | CConversionAcquired | +25,000 | $0.00 | $0 | 833,738 | Direct | |
| Jun 5, 2024 | Class A Common Stock | GGiftDisposed | −25,000 | $0.00 | $0 | 808,738 | Direct | |
| Jun 5, 2024 | Class A Common Stock | SSaleDisposed | −50,000 | $8.42 | −$421,000 | 758,738 | Direct | |
| Jun 6, 2024 | Class A Common Stock | SSaleDisposed | −50,000 | $9.00 | −$450,000 | 708,738 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2024 | Class A Common Stock | CConversionDisposed | −25,000 | $0.00 | $0 | 6,401,700 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.